Lithium ameliorates neural differentiation restoring cell death balance in Cornelia de Lange syndrome 2D and 3D

Chiara Parodi1, Antonella Lettieri1, Paolo Grazioli1

  • 1Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Cell Death Discovery
|March 28, 2026
PubMed

Insights

Cornelia de Lange syndrome (CdLS) neurodevelopmental deficits may be improved by lithium, which activates the WNT pathway. This study used human neural models to show lithium enhances neuronal differentiation in CdLS models.

Area of Science:

  • Genetics
  • Neuroscience
  • Developmental Biology

Background:

  • Cornelia de Lange syndrome (CdLS) is a rare genetic disorder impacting the central nervous system, causing neurodevelopmental delays with no current treatments.
  • CdLS arises from genetic variants affecting the cohesin complex or its regulators, disrupting crucial developmental pathways like the WNT pathway.
  • Understanding the molecular mechanisms underlying CdLS neurodevelopmental deficits is critical for therapeutic development.

Purpose of the Study:

  • To investigate the potential of lithium, a WNT pathway activator, to ameliorate the neural phenotype in Cornelia de Lange syndrome (CdLS).
  • To utilize advanced human in vitro models of the central nervous system to study CdLS-related neurobiological alterations.

Main Methods:

  • Developed and utilized 2D and 3D human in vitro models, including induced pluripotent stem cells (hiPSCs) differentiated into neural precursors, neurons, and brain organoids (BOs).
  • Mimicked HDAC8 haploinsufficiency in CdLS models to assess proliferation and differentiation defects.
  • Employed RNA-sequencing (RNA-seq) analysis on brain organoids to evaluate gene expression changes and pathway alterations.

Main Results:

  • CdLS models exhibited impaired neural proliferation and differentiation, particularly when mimicking HDAC8 haploinsufficiency.
  • RNA-seq analysis revealed downregulation of neuronal differentiation and the WNT pathway in CdLS brain organoids treated with an HDAC8 inhibitor.
  • Lithium treatment significantly enhanced neuronal differentiation in the CdLS models, suggesting a therapeutic benefit.

Conclusions:

  • Lithium shows promise as a therapeutic agent for ameliorating the neural phenotype in CdLS by activating the WNT pathway.
  • The study highlights the role of WNT pathway dysregulation and potential connections to lipid metabolism and cell death in CdLS neurodevelopmental deficits.
  • Human in vitro neural models are effective tools for dissecting disease mechanisms and testing potential therapeutic interventions for rare genetic disorders like CdLS.